Growth Metrics

Iridex (IRIX) Deferred Taxes (2015 - 2016)

Iridex's quarterly Deferred Taxes came in at $9.0 million in Q4 2016, up 5888.67% quarter-over-quarter from $150000.0 in Q2 2015.

Iridex has reported Deferred Taxes for 2 years, with the latest figure at $9.0 million in Q4 2016.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Deferred Taxes (Qtr)
1 Abbott Laboratories 152.82 Bn 146.17 Bn 6.27 Bn -
2 Stryker 115.07 Bn 112.19 Bn 3.81 Bn -33.00 Mn
3 Medtronic 95.25 Bn 87.08 Bn 5.76 Bn -101.00 Mn
4 Boston Scientific 71.38 Bn 70.17 Bn 3.61 Bn -351.00 Mn
5 Edwards Lifesciences 51.08 Bn 47.41 Bn 1.29 Bn -9.40 Mn
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn -
7 Dexcom 28.84 Bn 27.72 Bn 750.30 Mn 300,000.00
8 GE HealthCare Technologies 28.56 Bn 26.49 Bn 1.98 Bn -
9 Steris 20.71 Bn 20.30 Bn 697.10 Mn -16.70 Mn
10 Iridex 18.87 Mn 14.27 Mn 4.74 Mn -

Historic Data

Download Data 🔒
DateValue
Dec 31, 2016 8.98 Mn
Apr 4, 2015 150,000.00